Ben Andrews, Ph.D.Scientific Investigator at GlaxoSmithKline
Ben Andrews is a process chemist in Chemical Development at GlaxoSmithKline (Stevenage, UK). He has a background in organic chemistry with a PhD and postdoc in the field of asymmetric synthesis. In his 17 years at GSK he has contributed to the development of several mid to late phase compounds, from small molecules to oligonucleotides. He has 10 years’ experience of oligonucleotide manufacturing with expertise in synthesis, purification and isolation. He is a member of the European Pharma Oligonucleotide Consortium (EPOC) purge factor team, a co-lead of the ACS GCIPR oligonucleotide team and a GSK Fellow.